Ildamen,
Myofedrin,
Oxifedrine,
Oxiphedrin,
Oxyfedrine,
Oxyphedrin,
OXYFEDRINE,
15687-41-9,
DL-Oxyfedrine,
DL-Oxyfedrin,
UNII-DWL616XF1K,
Oxifedrinum,
DWL616XF1K,
Dl-Oxyphedrinum,
Oxyfedrinum [INN-Latin],
Oxifedrina [INN-Spanish],
Oxyfedrine [INN:BAN:DCF],
Oxifedrina,
Oxyfedrinum,
DL-3-((beta-Hydroxy-alpha-methylphenethyl)amino)-3'-methoxy-propiophenone,
Propiophenone, 3-((beta-hydroxy-alpha-methylphenethyl)amino)-3'-methoxy-, stereoisomer,
1-Propanone, 3-((2-hydroxy-1-methyl-2-phenylethyl)amino)-1-(3-methoxyphenyl)-, (R*,S*)-(+-)-,
NCGC00182060-02,
Oxyfedrine (INN),
AC1NUR0E,
SCHEMBL152553,
CHEMBL1651913,
DTXSID0023408,
3-(((alphaS,betaR)-beta-Hydroxy-alpha-methylphenethyl)amino)-3'-methoxypropiophenone,
CHEBI:135343,
1-Propanone, 3-((2-hydroxy-1-methyl-2-phenylethyl)amino)-1-(3-methoxyphenyl)-, (R-(R*,S*))-,
ZINC2018339,
AC-904,
AKOS025402433,
API0008730,
BC680172,
LS-125331,
D08321,
687O419,
UNII-H1CAC99B4D component GDYUVHBMFVMBAF-LIRRHRJNSA-N,
(1R,2S)-1-Phenyl-2-[2-(3-methoxybenzoyl)ethylamino]-1-propanol,
3-[[(1R,2S)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-(3-methoxyphenyl)propan-1-one,
3-{[(1S,2R)-2-hydroxy-1-methyl-2-phenylethyl]amino}-1-[3-(methyloxy)phenyl]propan-1-one,
21071-51-2,
Oxyfedrine HCl,
oxyphedrine,
Oxyfedrin,
Oxyfedrine [BAN:DCF:INN],
OXYFEDRINE HYDROCHLORIDE,
C19-H23-N-O3,
CID5489013,
L-3-[(beta-hydroxy-alpha-methylphenethyl)amino]-3'-methoxypropiophenone,
3-[[(1S,2R)-2-Hydroxy-1-methyl-2-phenylethyl]amino]-1-(3-methoxyphenyl)-1-propanone,
Propiophenone, 3-[(.beta.-hydroxy-.alpha.-methylphenethyl)amino]-3'-methoxy-, L-,
1-Propanone, 3-[(2-hydroxy-1-methyl-2-phenylethyl)amino]-1-(3-methoxyphenyl)-, [R-(R*,S*)]-,